Plasma viral HIV-@ RNA level , CD@ + T-cell counts , and drug resistance were evaluated among seroconverting women in the FEM-PrEP trial ( clinicaltrials.gov NCT@ ) using standard clinical tests , allele-specific PCR ( ASPCR ) , and by deep sequencing .